Fig. 3From: The case for a universal hepatitis C vaccine to achieve hepatitis C eliminationRelative reduction in incidence by 2030, projected for the optimal WHO incidence reduction target strategies without (top) and with (bottom) a vaccine available. Projections assume 80% coverage of testing, treatment and vaccination programmes, and a maximum testing frequency of six monthly among PWIDBack to article page